Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Carl Morrison

5PUBLICATIONS

0CO-AUTHORS

Molecular targetsCellular immunologyPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Feb 03, 2019

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline

|Jan 26, 2019

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.

Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline

|Jan 20, 2019

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.

Grace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos

|Jan 08, 2019

Identification of targets for prostate cancer immunotherapy.

Antonios Papanicolau-Sengos, Yuanquan Yang, Sarabjot Pabla

|May 11, 2018

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden.

Carl Morrison, Sarabjot Pabla, Jeffrey M Conroy

Pageof 1

Frequent Collaborators

Frequent Collaborators

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on : Nov 12, 2010

See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on : Nov 12, 2010

See more related videos